FLEET ENEMA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 19g, dibasic sodium phosphate 7g; per 118mL; latex-free; contains 4.4g sodium per enema.
Fleet, C.B., Company
Indications for FLEET ENEMA:
Occasional constipation or bowel cleansing before rectal exam.
1 enema rectally daily; may be used up to 7 days. Results usually within 1–5mins; re-evaluate if no relief after 7 days.
Use other forms.
Megacolon. Bowel obstruction. Imperforate anus. CHF.
Sodium restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence. Pregnancy. Nursing mothers.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Original enema—133mL; Extra—230mL
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds